Neurobane

Neurobane is an R&D company dedicated to revolutionizing psychiatric care through neuroimaging and AI. We're developing an EEG + fNIRS multimodal system that provides psychiatrists with pre-assessment patient reports indicating the likelihood of diagnosis and treatment efficacy. Our mission addresses a critical problem in mental healthcare: 45% of psychiatric diagnoses are inaccurate, and 65% of prescribed medications are ineffective, resulting in an 81% failure rate for the 25 million Americans who received psychiatric care in 2021. One root cause is the lack of objective diagnostics - unlike physical conditions, where X-rays and MRIs guide treatment, psychiatric care often relies on brief intake sessions. Neurobane is currently expanding its team to support upcoming validation and research studies, with a focus on transforming psychiatric care from notoriously inconsistent to incredibly reliable. By providing objective data through our platform, we aim to make psychiatric treatment faster, more accurate, and widely accessible to psychiatric offices and rehabilitation centers nationwide. Our technology promises to dramatically improve patient outcomes and reduce recovery times from years to months, setting a new standard for psychiatric care in the 21st century.